Dr. Ayodele Ayoola, M.D

NPI: 1164558763
Total Payments
$256,536
2024 Payments
$5,040
Companies
57
Transactions
589
Medicare Patients
2,022
Medicare Billing
$290,743

Payment Breakdown by Category

Other$149,548 (58.3%)
Travel$46,753 (18.2%)
Consulting$41,953 (16.4%)
Food & Beverage$15,967 (6.2%)
Education$2,316 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $149,548 63 58.3%
Travel and Lodging $46,753 103 18.2%
Consulting Fee $41,953 26 16.4%
Food and Beverage $15,967 359 6.2%
Education $2,316 38 0.9%

Top Paying Companies

Company Total Records Latest Year
Taiho Oncology, Inc. $97,956 102 $0 (2021)
Novartis Pharmaceuticals Corporation $45,102 62 $0 (2023)
E.R. Squibb & Sons, L.L.C. $41,040 71 $0 (2024)
Lilly USA, LLC $24,833 56 $0 (2022)
Celgene Corporation $12,126 21 $0 (2024)
JAZZ PHARMACEUTICALS INC. $6,999 13 $0 (2023)
AstraZeneca Pharmaceuticals LP $6,606 23 $0 (2024)
Exelixis Inc. $6,490 20 $0 (2023)
Kite Pharma, Inc. $3,894 4 $0 (2019)
Bayer Healthcare Pharmaceuticals Inc. $1,658 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,040 31 AstraZeneca Pharmaceuticals LP ($3,264)
2023 $4,981 32 Exelixis Inc. ($2,939)
2022 $29,372 78 E.R. Squibb & Sons, L.L.C. ($26,371)
2021 $18,858 49 Celgene Corporation ($11,276)
2020 $8,824 33 Novartis Pharmaceuticals Corporation ($4,106)
2019 $72,064 126 Taiho Oncology, Inc. ($36,244)
2018 $52,562 97 Taiho Oncology, Inc. ($28,889)
2017 $64,835 143 Taiho Oncology, Inc. ($29,611)

All Payment Transactions

589 individual payment records from CMS Open Payments — Page 1 of 24

Date Company Product Nature Form Amount Type
12/18/2024 Menarini Silicon Biosystems, Inc. Cellsearch (Device) Food and Beverage Cash or cash equivalent $19.35 General
Category: Diagnostics
12/04/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $122.31 General
Category: ONCOLOGY
12/03/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $134.98 General
Category: Oncology
11/14/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $5.41 General
Category: Hematology
11/13/2024 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $109.38 General
Category: Oncology
11/13/2024 Menarini Silicon Biosystems, Inc. Cellsearch (Device) Food and Beverage Cash or cash equivalent $22.50 General
Category: Diagnostics
10/26/2024 Tempus AI, Inc Food and Beverage In-kind items and services $21.41 General
10/24/2024 Celgene Corporation Food and Beverage Cash or cash equivalent $111.61 General
10/23/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $7.38 General
Category: Hematology
10/16/2024 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $124.74 General
Category: Acute Myeloid Leukemia
10/02/2024 SEAGEN INC. Education In-kind items and services $99.00 General
08/21/2024 PFIZER INC. ELREXFIO (Drug), ADCETRIS Food and Beverage In-kind items and services $2.48 General
Category: ONCOLOGY
08/15/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $5.87 General
Category: Oncology
08/12/2024 Myriad Genetic Laboratories, Inc. MYRISK (Device) Food and Beverage In-kind items and services $54.82 General
Category: ONCOLOGY
07/24/2024 PFIZER INC. INLYTA (Drug), XTANDI, TALZENNA Food and Beverage In-kind items and services $10.24 General
Category: ONCOLOGY
07/11/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $3.95 General
Category: Hematology
06/05/2024 E.R. Squibb & Sons, L.L.C. ONUREG (Drug) Food and Beverage Cash or cash equivalent $125.00 General
Category: Oncology
05/22/2024 AstraZeneca Pharmaceuticals LP IMFINZI (Biological) Consulting Fee Cash or cash equivalent $525.00 General
Category: Oncology
05/08/2024 PFIZER INC. Education In-kind items and services $99.00 General
05/03/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $20.92 General
Category: Oncology
05/02/2024 Janssen Biotech, Inc. DARZALEX (Biological) Education In-kind items and services $99.00 General
Category: Oncology
04/29/2024 AstraZeneca Pharmaceuticals LP IMFINZI (Biological) Consulting Fee Cash or cash equivalent $2,497.50 General
Category: Oncology
04/24/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $124.00 General
Category: Oncology
04/24/2024 PFIZER INC. INLYTA (Drug), XTANDI, TALZENNA Food and Beverage In-kind items and services $4.96 General
Category: ONCOLOGY
04/22/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $4.09 General
Category: Hematology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 497 873 $383,474 $77,252
2022 8 522 1,082 $322,563 $80,187
2021 10 507 1,093 $219,328 $74,573
2020 9 496 975 $212,268 $58,731
Total Patients
2,022
Total Services
4,023
Medicare Billing
$290,743
Procedure Codes
36

All Medicare Procedures & Services

36 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 160 352 $187,968 $36,538 19.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 143 267 $96,120 $19,667 20.5%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 66 66 $44,418 $8,867 20.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 57 67 $16,415 $3,343 20.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 21 53 $13,727 $3,282 23.9%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 12 30 $11,190 $2,795 25.0%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 16 16 $7,872 $1,629 20.7%
38222 Biopsy and aspiration of bone marrow sample for diagnosis Facility 2023 11 11 $3,080 $615.08 20.0%
99442 Telephone medical discussion with physician, 11-20 minutes Facility 2023 11 11 $2,684 $515.60 19.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 171 530 $145,349 $37,801 26.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 95 183 $94,137 $20,579 21.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 140 242 $37,817 $11,491 30.4%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 29 29 $17,474 $4,091 23.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 29 40 $10,258 $2,239 21.8%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 19 19 $7,487 $1,744 23.3%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2022 22 22 $4,896 $1,275 26.0%
38222 Biopsy and aspiration of bone marrow sample for diagnosis Facility 2022 17 17 $5,145 $968.48 18.8%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 209 647 $135,223 $48,327 35.7%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 141 265 $36,040 $13,668 37.9%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 32 32 $11,104 $3,405 30.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 17 32 $7,776 $1,825 23.5%
99203 New patient outpatient visit, total time 30-44 minutes Facility 2021 27 27 $5,508 $1,770 32.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 14 14 $7,182 $1,511 21.0%
38222 Diagnostic aspirations and biopsies of bone marrow Facility 2021 23 25 $7,875 $1,424 18.1%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Facility 2021 20 24 $3,264 $1,301 39.9%

About Dr. Ayodele Ayoola, M.D

Dr. Ayodele Ayoola, M.D is a Internal Medicine healthcare provider based in Hershey, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164558763.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ayodele Ayoola, M.D has received a total of $256,536 in payments from pharmaceutical and medical device companies, with $5,040 received in 2024. These payments were reported across 589 transactions from 57 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($149,548).

As a Medicare-enrolled provider, Ayoola has provided services to 2,022 Medicare beneficiaries, totaling 4,023 services with total Medicare billing of $290,743. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Medical Oncology
  • Location Hershey, PA
  • Active Since 02/26/2007
  • Last Updated 09/10/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1164558763

Products in Payments

  • Lonsurf (Drug) $97,956
  • KISQALI (Drug) $42,078
  • CYRAMZA (Drug) $17,585
  • EMPLICITI (Biological) $10,816
  • Cabometyx (Drug) $3,540
  • IMFINZI (Biological) $3,273
  • CABOMETYX (Drug) $2,939
  • CALQUENCE (Drug) $2,901
  • PIQRAY (Drug) $2,850
  • OPDIVO (Biological) $2,395
  • ALIMTA (Drug) $2,215
  • Aliqopa (Drug) $900.00
  • Stivarga (Drug) $655.50
  • JEVTANA (Drug) $510.85
  • TECENTRIQ (Biological) $495.66
  • Pomalyst (Drug) $381.69
  • SIR-Spheres Microspheres (Device) $361.69
  • Tavalisse (Drug) $317.27
  • ADCETRIS (Biological) $307.38
  • Kyprolis (Biological) $306.21

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Hershey